| 000 | 01868 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515053716.0 | ||
| 264 | 0 | _c20070320 | |
| 008 | 200703s 0 0 eng d | ||
| 022 | _a0030-2414 | ||
| 024 | 7 |
_a10.1159/000098813 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAlagbala, Adebusola A | |
| 245 | 0 | 0 |
_aAntitumor effects of two less-calcemic vitamin D analogs (Paricalcitol and QW-1624F2-2) in squamous cell carcinoma cells. _h[electronic resource] |
| 260 |
_bOncology _c2006 |
||
| 300 |
_a483-92 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 |
_aBromodeoxyuridine _xmetabolism |
| 650 | 0 | 4 |
_aCalcitriol _xanalogs & derivatives |
| 650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xdrug therapy |
| 650 | 0 | 4 |
_aCell Cycle _xdrug effects |
| 650 | 0 | 4 |
_aCell Cycle Proteins _xmetabolism |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCyclin-Dependent Kinase 2 _xmetabolism |
| 650 | 0 | 4 |
_aCyclin-Dependent Kinase Inhibitor p21 _xmetabolism |
| 650 | 0 | 4 |
_aDNA, Neoplasm _xdrug effects |
| 650 | 0 | 4 |
_aErgocalciferols _xpharmacology |
| 650 | 0 | 4 |
_aMAP Kinase Kinase Kinase 1 _xmetabolism |
| 650 | 0 | 4 |
_aMAP Kinase Kinase Kinases _xmetabolism |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C3H |
| 650 | 0 | 4 |
_aMitogen-Activated Protein Kinase 3 _xmetabolism |
| 650 | 0 | 4 |
_aOncogene Protein v-akt _xmetabolism |
| 650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
| 650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
| 700 | 1 | _aJohnson, Candace S | |
| 700 | 1 | _aTrump, Donald L | |
| 700 | 1 | _aPosner, Gary H | |
| 700 | 1 | _aFoster, Barbara A | |
| 773 | 0 |
_tOncology _gvol. 70 _gno. 6 _gp. 483-92 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000098813 _zAvailable from publisher's website |
| 999 |
_c16801152 _d16801152 |
||